C12P 21/005
Glycopeptides, glycoproteins
Official title: {Glycopeptides, glycoproteins}
C12P21/005 (Glycopeptides, glycoproteins) appears on 916 US grants and 1,476 published applications in this corpus.
Search patents in C12P- Granted patents
- 916
- Published applications
- 1,476
- Assignees
- 541
- Inventors
- 2,299
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 3 | 0 |
| 1978 | 5 | 0 |
| 1979 | 9 | 0 |
| 1980 | 7 | 0 |
| 1981 | 9 | 0 |
| 1982 | 5 | 0 |
| 1983 | 8 | 0 |
| 1984 | 2 | 0 |
| 1985 | 4 | 0 |
| 1986 | 2 | 0 |
| 1987 | 5 | 0 |
| 1988 | 3 | 0 |
| 1989 | 2 | 0 |
| 1990 | 3 | 0 |
| 1991 | 0 | 0 |
| 1992 | 3 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 5 | 0 |
| 1999 | 4 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 0 |
| 2002 | 6 | 13 |
| 2003 | 7 | 21 |
| 2004 | 7 | 22 |
| 2005 | 6 | 39 |
| 2006 | 12 | 41 |
| 2007 | 20 | 44 |
| 2008 | 16 | 48 |
| 2009 | 13 | 45 |
| 2010 | 35 | 57 |
| 2011 | 34 | 71 |
| 2012 | 31 | 54 |
| 2013 | 32 | 78 |
| 2014 | 57 | 115 |
| 2015 | 68 | 83 |
| 2016 | 67 | 106 |
| 2017 | 55 | 103 |
| 2018 | 50 | 52 |
| 2019 | 58 | 74 |
| 2020 | 50 | 61 |
| 2021 | 43 | 78 |
| 2022 | 38 | 67 |
| 2023 | 41 | 58 |
| 2024 | 37 | 67 |
| 2025 | 30 | 45 |
| 2026 | 16 | 34 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- FlmG-dependent soluble protein O-glycosylation systems in bacteria29 Sep 2026US 12,747,442 B2Universite De Geneve
- Methods of protein production22 Sep 2026US 12,742,192 B2Genentech, Inc.
- Cell culture process for producing RSV F protein15 Sep 2026US 12,734,231 B2Pfizer Inc.
- Low-cost, thermostable, lyophilized, cell-free protein synthesis platform15 Sep 2026US 12,735,734 B2Northwestern University
- Glycoengineering using Leishmania cells28 Jul 2026US 12,692,472 B2Limmatech Biologics AG
- Methods of increasing sialic acid levels in recombinant glycosylated proteins8 Oct 2026US 2026/0308601 A1Denali Therapeutics Inc.
- Method for the Production of Pharmaceutically Active Recombinant Human Low Molecular Weight Urokinase8 Oct 2026US 2026/0308654 A1Cerbios-Pharma SA
- Methods and means for the production of ig-like molecules8 Oct 2026US 2026/0308655 A1Merus N.V.
- Method for producing solution and solution1 Oct 2026US 2026/0297641 A1Honda Motor Co., Ltd.
- Fucosidase Enzymes For Therapeutic Applications1 Oct 2026US 2026/0297642 A1Universiteit Gent
Most cited
By later US patents
- Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity604US 6,602,684 B1GlycArt Biotechnology AG · 2003
- Cells producing antibody compositions with increased antibody dependent cytotoxic activity247US 6,946,292 B2Kyowa Hakko Kogyo Co., Ltd. · 2005
- Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins198US 9,303,079 B2Moderna Therapeutics, Inc. · 2016
- Modified polynucleotides for the production of biologics and proteins associated with human disease196US 8,999,380 B2Moderna Therapeutics, Inc. · 2015
- Transgenic transchromosomal rodents for making human antibodies195US 7,041,870 B2Kirin Brewery Co., Ltd. · 2006